This a cohort study of KPNC patients initiating interferon-free treatment for HCV infection, with the following specific aims: 1) Determine the short- and long-term effectiveness of interferon-free treatment for HCV infection, 2) determine the safety of interferon-free treatment for HCV infection, and 3) compare the effectiveness and safety of 8- versus 12-week interferon-free treatment for HCV infection. Our results will guide clinical decision-making to maximize the effectiveness and safety of HCV treatment for KPNC patients.
Effectiveness and safety of interferon-free treatment for hepatitis C virus (HCV) infection in a clinical practice setting
Investigator: Silverberg, Michael
Funder: The Permanente Medical Group